Furosemide and Teveten drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Furosemide and Teveten. Common interactions include cardiac failure among females and chronic obstructive pulmonary disease among males.

The phase IV clinical study analyzes what interactions people who take Furosemide and Teveten have. It is created by eHealthMe based on reports of 44 people who take Furosemide and Teveten from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

44 people who take Furosemide and Teveten together, and have interactions are studied.


What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 253,511 Furosemide users for its effectiveness, alternative drugs and more.

What is Teveten?

Teveten has active ingredients of eprosartan mesylate. It is often used in high blood pressure. eHealthMe is studying from 1,469 Teveten users for its effectiveness, alternative drugs and more.

Number of Furosemide and Teveten reports submitted per year:

Furosemide and Teveten drug interactions.

Common Furosemide and Teveten drug interactions by gender *:

female:

  1. Cardiac failure
  2. Contusion
  3. Diarrhoea
  4. Lip oedema
  5. Oral pain
  6. Arthralgia
  7. Balance disorder
  8. Bone disorder
  9. Bradycardia
  10. Cardiac failure congestive

male:

  1. Chronic obstructive pulmonary disease
  2. Dyspnoea
  3. Accident
  4. Acute myocardial infarction
  5. Blood pressure fluctuation
  6. Cardiac arrest
  7. Cardiac failure
  8. Cellulitis
  9. Cough
  10. Death

Common Furosemide and Teveten drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Erythema multiforme
  2. Urticaria generalised

50-59:

  1. Cellulitis
  2. Cough
  3. Pain in limb
  4. Pyrexia
  5. Rigors

60+:

  1. Cardiac failure
  2. Dyspnoea
  3. Bone disorder
  4. Bradycardia
  5. Cardiac failure congestive
  6. Chronic obstructive airways disease
  7. Coma
  8. Contusion
  9. Eye swelling
  10. Fall

Common conditions people have *:

  1. High Blood Cholesterol: 10 people, 22.73%
  2. Sleep Disorder: 4 people, 9.09%
  3. Depression: 4 people, 9.09%
  4. Cardiac Disorder: 4 people, 9.09%
  5. Essential Hypertension (primary hypertension): 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and Teveten?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Furosemide and Teveten:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Furosemide interactions:

Browse all interactions between Furosemide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Teveten interactions:

Browse all interactions between Teveten and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on furosemide and eprosartan mesylate (the active ingredients of Furosemide and Teveten, respectively), and Furosemide and Teveten (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: